Zydus Wellness Ltd Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Published 7 Aug 2026 | Food Products | Market Cap: ₹16.9K Cr

The company expects to sustain double-digit top-line revenue growth in FY '26 and beyond. Management expects to sustain double-digit top-line growth in FY '26 and beyond.

From Zydus Wellness Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

491

Market Cap

₹16.9K Cr

P/E Ratio

76.2

How does Zydus Wellness Ltd rank in Food Products?

Compare Zydus Wellness Ltd against every Food Products company this quarter on revenue, margins and earnings-call signals.

View Food Products leaderboard →

Zydus Wellness Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.5K Cr, net profit ₹162 Cr.

Full financials →

📊 Revenue & Sales Performance

  • The company expects to sustain double-digit top-line revenue growth in FY '26 and beyond.
  • Personal Care segment has shown consistent double-digit growth over the last 6-7 quarters, driven by category expansion and market leadership.
  • Digital channel (e-commerce) now contributes about 10%-11% of revenue and growing faster than other segments.
  • Food & Nutrition segment growth is improving, although some sizable brands like Complan show lower growth; initiatives underway to improve this.
  • New product launches like protein chips and cookies under Max Protein are positively building momentum.
  • Management remains focused on driving growth ahead of the industry, targeting better performance and improving profitability.
  • Innovations, digital marketing, AI, and data analytics are key to capturing consumer insights and sales efficiency for future growth.
  • Market shifts towards organized trade and quick commerce are secular trends supporting sustained growth.

📈 Profitability & Margins

  • Management expects to sustain double-digit top-line growth in FY '26 and beyond.
  • EBITDA growth is projected to be in sync with or faster than top-line growth.
  • Gross margins have been improving steadily over 6-7 quarters and are expected to continue rising, supported by pricing power, cost efficiencies, and inflation management.
  • Operating margins are on an improving trajectory, with management confident that the improvement journey is not yet complete.
  • Synergies from the Ritebite acquisition are expected to drive margin expansion, with the business anticipated to be EPS accretive by FY '26.
  • Deferred tax liabilities impact net profit but operating profit improvements and reduction in debt are expected to boost margins.
  • Focus on cost control, product mix optimization, and expanding organized trade channels is expected to enhance profitability.
  • Management anticipates EBITDA margins potentially rising to 17%-18% in the coming 6-8 quarters.

🏗️ Capital Expenditure Plans

The transcript and report excerpts do not explicitly mention any specific current or future capital expenditure (capex) or strategic capital investments by Zydus Wellness Limited. However, some relevant points include: - Focus on category development and brand extension (e.g., extending Nutralite into cheese, mayonnaise; Sugar Free into chocolates and cookies) which may imply marketing or product development investments. - Acquisitions have been described as "bolt-ons" to fill portfolio gaps, with Ritebite acquisition expected to be EPS accretive by FY '26. - Investments in digital and AI capabilities for improved consumer engagement and sales force efficiency. - Advertising investments increased post-2021-23 to support growth, expected not to accelerate at the same past pace. - No specific capex amounts, timelines, or strategic investment projects were disclosed in the available transcript. Overall, no direct details on capex were provided, but strategic investments focus on brand extensions, acquisitions, and digital/AI initiatives.

💰 Fundraising & Capital Structure

Based on the information on pages 1-21 of the provided document from Zydus Wellness Limited (February 04, 2025): - There is no explicit mention of any current or planned new fundraising through equity or debt in the latest call transcript. - Management discusses improving profitability and reducing debt over the coming years but does not specify any new debt issuance. - The focus is on operational growth, margin improvement, and bolt-on acquisitions financed prudently. - No direct commentary on raising capital through equity or fresh debt is provided in the Q&A or closing remarks. - The company is emphasizing organic growth, margin expansion, and strategic acquisitions rather than capital raising. Hence, no clear indication of imminent or planned fundraising through debt or equity as per the latest update.

📋 Order Book & Pipeline

The transcript for Zydus Wellness Limited’s Q3 FY2025 earnings call does not provide specific details about the current or expected order book or pending orders. However, relevant insights related to business performance and outlook include: - Strong focus on double-digit growth in revenue and EBITDA. - Confidence in sustaining growth momentum with new product launches and expansion in digital channels. - Anticipation of revival in demand, especially in urban areas, supported by government measures in Budget 2025. - Continued emphasis on innovation and consumer engagement, especially in categories like nutrition bars and protein products. - Executives discussed growth strategies but did not disclose specific order book or pending order volumes. No quantitative or qualitative disclosure on order backlog or pending orders is mentioned in the available transcript.

Key Metrics

Frequently Asked Questions

What were Zydus Wellness Ltd Q3 FY25 results?

The company expects to sustain double-digit top-line revenue growth in FY '26 and beyond. Management expects to sustain double-digit top-line growth in FY '26 and beyond.

What is Zydus Wellness Ltd share price analysis?

Zydus Wellness Ltd currently shows a neutral. The stock trades at a P/E of 76.2 with a market cap of ₹16,875 Cr. Investors should review the full earnings analysis for detailed insights.

Is Zydus Wellness Ltd planning capital expenditure?

The transcript and report excerpts do not explicitly mention any specific current or future capital expenditure (capex) or strategic capital investments by Zydus Wellness Limited.

Keep Zydus Wellness Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Food Products this season

  • Bikaji Foods (Q3 FY25)

    Expansion plans include ramping up capacity to reach 65%-70% utilization over the next 3-4 years. Key concall takeaways from Bikaji Foods International Ltd's…

  • Dodla Dairy (Q3 FY25)

    EBITDA margins are around 7-9% for key products like ghee; overall EBITDA margins are stable at about 10.6% for Q3 FY25. Key concall takeaways from Dodla Dairy…

  • Godrej Agrovet (Q3 FY25)

    Visibility for FY26 CDMO growth is around 30% to 35%, with potential to reach 40%, pending one or two customer confirmations. Key concall takeaways from Godrej…

  • Kings Infra (Q3 FY25)

    With international competitors like Ecuador shrinking production by 30-40%, Indian exports are gaining advantage. Key concall takeaways from Kings Infra…